This article has an accompanying continuing medical education activity, also eligible for MOC credit, on page e89. Learning Objective-Upon completion of this activity, successful learners will be able to estimate efficacy of colonoscope distal attachment devices in increasing adenoma detection rate.
C olorectal cancer (CRC) is the third most common cancer and the third leading cause of cancerrelated mortality worldwide. 1 Because colon carcinogenesis follows the well-known adenoma-carcinoma sequence, 2 early interruption of this sequence by means of screening and surveillance programs and effective polypectomy was found to have a significant impact on patient survival. 3 The efficacy of colonoscopy in preventing CRC occurrence is strictly dependent on completeness of the procedure and identification of precancerous lesions. Therefore, the adenoma detection rate (ADR), defined as the percentage of colonoscopies with at least 1 adenoma identified, has been recognized as a key performance measure for quality colonoscopy. 4 Unfortunately, ADR in screening procedures varies widely, ranging from 5% to 37.5%, 5 depending on several procedural and technological factors such as bowel preparation, 6 withdrawal time, 7 second right colon inspection, 8 and use of new technologies. Among the recent improvements in lower digestive endoscopy, several distal attachment devices that aim to enhance visualization behind colonic folds and curves have been developed 9 ; however, there are limited data on the comparative efficacy of these devices derived only from previous traditional pairwise meta-analyses providing conflicting results. 9, 10 In addition, there was no systematic assessment of the quality of evidence, which can inform clinical guidelines. In contrast to pairwise meta-analyses, network meta-analysis can inform comparative effectiveness of multiple interventions and synthesize evidence across a network of randomized controlled trials (RCTs). This method involves the simultaneous analysis of direct evidence (from RCTs directly comparing treatments of interest) and indirect evidence (from RCTs comparing treatments of interest with a common comparator), to calculate a mixed-effect estimate as the weighted average of the two.
In this systematic review, we performed a pairwise meta-analysis and network meta-analysis combining direct and indirect evidence comparing the relative efficacy of several add-on devices (Cap, Endocuffs, Endorings) for the improvement of colon ADR. We used Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria for network metaanalysis to appraise quality of evidence. 11 
Methods
This systematic review has been reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement and was conducted following an a priori established protocol. 12 
Selection Criteria
Studies included in this meta-analysis were RCTs published either in full-text or as congress abstracts that met the following inclusion criteria: (1) patients were adults undergoing elective colonoscopy; (2) the intervention used was distal attachment devices including Cap, Endocuffs, and Endorings; (3) the comparator was another add-on device or standard colonoscopy (SC); and (4) the outcome was adenoma detection rate as the primary outcome, and polyp detection rate (PDR), cecal intubation rate, and cecal intubation time as secondary outcomes.
We excluded observational studies, trials conducted with new nonstandard endoscopes, 13 trials not reporting any of the aforementioned outcomes, [14] [15] [16] and comparing different attachments of the same device. 17 
Search Strategy
Supplementary Table 1 reports the search strategy followed in the meta-analysis.
A computerized bibliographic search was performed on PubMed/Medline and Embase, with no language restriction, independently by 2 authors (A.F., V.D.P.) using the following text words and corresponding Medical Subject Heading/Emtree terms: "colonoscopy" OR "endoscopy" AND "adenoma" OR "polyp" AND "cap" OR "hood" OR "endocuff" OR "endorings" through March 2017. A complementary manual search was performed on additional databases (Google Scholar, Cochrane library) and by checking the references of all the main review articles on this topic to identify possible additional studies. In cases of repetitive publications from the same population, only the most recent and complete articles were included.
The quality of the included studies was assessed by 2 authors independently (A.F., V.D.P.) according to the Cochrane Collaboration's tool for assessing the risk of bias. 18 Any disagreements were addressed by reevaluation and after a third opinion was sought (N.M.).
Statistical Analysis
A direct meta-analysis was performed using a random-effects model to estimate pooled relative risk (RR) and 95% CIs. 19 We assessed statistical heterogeneity using the I 2 statistic, with values greater than 50% indicating substantial heterogeneity, and small study effects were assessed by examining funnel plot asymmetry. Direct comparisons were performed using RevMan v5.3 (Cochrane Collaboration, Copenhagen, Denmark). Next, we conducted a network meta-analysis using a multivariate random-effects meta-regression as described elsewhere. 20 We used a frequentist approach based on a random-effects consistency model and provided a point estimate from the network along with 95% CIs from the frequency distribution of the estimate.
Subgroup analysis was conducted based on the study location (Asia vs West), and lesion size ( 5 vs >5 mm). Multiple sensitivity analyses were performed to assess the robustness of our findings. These were based on the following: (1) restricting analysis to studies conducted exclusively by experienced endoscopists (not trainees); (2) exclusion of studies published only in abstract form; and (3) exclusion of tandem studies (the addition of a second procedure has the benefit of unblinded secondlook colonoscopy).
For the primary outcome (ADR), the quality of evidence derived from the pairwise and network metaanalysis was judged using the GRADE framework (Supplementary Table 2 ). Briefly, evidence was rated down for the presence of any of the following factors: risk of bias in the literature, inconsistency, indirectness, imprecision, and publication bias. The quality of indirect estimates was derived initially from the lowest quality of first-order loops for direct estimates contributing to the indirect estimates. The quality of the network metaanalysis was derived from the quality of the combination of direct and indirect estimates and transitivity of trials. When moderate-to high-quality evidence was available from direct/pairwise estimates, they were used preferentially; when pairwise estimates provided only low or very low quality of evidence or if there were no pairwise comparisons, then estimates from network meta-analysis were used to rate the quality of evidence.
Finally, we generated estimates of absolute event rates (or absolute risk) by calculating the estimated risk difference (also known as absolute risk reduction) by combining the risk ratio (RR) for each intervention against standard colonoscopy and the median standard colonoscopy response rate for the respective outcome across trial as the assumed control risk (ACR), by using the following formula: risk difference ¼ 100
The risk difference, which represents the difference between the event rates in the intervention and control groups, was added back to the assumed control risk to generate an estimate of the absolute risk for each intervention. Ninety-five percent CIs for the estimates Figure 1 . Study selection flow chart. were generated using the 95% credible intervals of the risk ratios in the earlier-described calculations. Estimates of absolute risk were generated using the GRADEpro version 3.6.1 (McMaster University, Hamilton, Canada, 2014).
Network meta-analysis was conducted with R package netmeta (Foundation for Statistical Computing, Vienna, Austria).
Results

Included Studies
From 2369 unique studies identified using the search strategy, we included 25 RCTs in the network metaanalysis (Figure 1 ), whose characteristics are summarized in Table 1 Figure 2 shows the available direct comparisons and network of trials.
Supplementary Table 3 describes the baseline characteristics of patients included in these trials. Males formed the majority of participants in the included studies, although most detected polyps were under 5 mm. Baseline patient characteristics and prognostic factors were distributed comparably in the active and comparator groups and across different trials. Seven RCTs also included colonoscopies performed by trainees/inexperienced endoscopists. 21, 23, 26, 27, 31, 33, 34 Quality assessment was performed in the context of the primary outcome, and overall the studies were believed to be at moderate risk of bias, mainly owing to performance and detection bias related to the unblinded design of the included RCTs. Six abstracts 35, 36, 38, 41, 42, 45 and 5 full-text reports 21, 23, 27, 31, 34 were considered at higher risk of bias because of incomplete outcome reporting. Overall and study-level quality assessments are summarized in Supplementary Figure 1A and B, respectively.
Adenoma Detection Rate
Pairwise meta-analysis. Overall, based on 20 RCTs Figure 2) . This would translate into a potential absolute increase in ADR to 11.3% and 45.2% Figure 3) . Based on these findings, as reported in Table 2 , add-on devices would determine a very modest benefit in adenoma detection in low-performing endoscopists with a baseline ADR of 10% (anticipate ADR, 11%; 95% CI, 10%-12% with Cap; and 13% increase; 95% CI, 8%-18% with Endocuff). On the other hand, in a scenario with highperforming endoscopists with a baseline ADR of 40%, cap still would lead to minimal improvements in terms of detection rates (anticipate ADR, 42%; 95% CI, 40%-44%), whereas more considerable results would be achieved with Endocuff (48%; 95% CI, 41%-56%). It is noteworthy that, because of the high heterogeneity and the small number of trials included in each comparison, statistical significance should be interpreted with caution. In the only head-to-head comparison between add-on devices, Endocuff and Cap were comparable (RR, 0.94; 95% CI, 0.80-1.11; P ¼ .48).
Network meta-analysis. With network meta-analysis, we calculated the mixed-effect estimate as a weighted average of both pairwise (where available) and indirect treatment effects, and the overall results were largely similar with overlapping CIs and no evidence of inconsistency. Endocuff was significantly superior to SC (RR, 1.21; 95% CI, 1.03-1.41), whereas Endorings showed a trend toward improved ADR as compared with SC (RR, 1.70; 95% CI, 0.86-3.36).
Comparative analysis of different add-on devices yielded very low quality evidence, with no significant differences between the 3 devices, although ADR detection with Endorings was numerically higher than Endocuff (RR, 1.44; 95% CI, 0.72-2.88) and Cap (RR, 1.56; 95% CI, 0.78-3.11).
Results were stable in sensitivity analyses based on the following: (1) restricting the analysis to studies conducted exclusively by experienced endoscopists; (2) exclusion of studies published only in abstract form; and (3) exclusion of tandem RCTs (Supplementary Table 4) .
Quality of evidence. There was no inconsistency, indirectness, or publication bias for any of the direct comparisons. For several comparisons, evidence was rated down for imprecision because of wide CIs or heterogeneity and because of the high risk of performance and detection bias. Overall, based on pairwise estimates, there was low-quality evidence supporting the use of Endocuff over SC for improving ADR and suggesting comparability of Cap and SC (Table 2) . For all other comparisons, there was very low quality evidence supporting the use of Endorings over SC and supporting the use of Endorings over the other 2 devices. Finally, very low quality evidence suggested comparability between Endocuff and Cap ( Table 2) .
Secondary Outcomes
Polyp detection rate. Based on 25 RCTs 21-45 (16,103 patients), distal attachment devices determined increased rates of polyp detection (RR, 1.14; 95% CI, 1.06-1.23; P < .001) with high heterogeneity (I 2 ¼ 74%). Results of direct meta-analyses divided according to the device used are reported in Supplementary Figure 4 . Network meta-analysis considering PDR as the outcome provided results similar to those described earlier for ADR (Table 3) .
Cecal intubation time and cecal intubation rate.
Sixteen RCTs Figure 5) . Again, because of the reasons reported earlier, statistical significance should be interpreted with caution. Network metaanalysis suggested comparability of Cap and Endocuff (-0.07 min; -2.03 to 1.88) and considerable lengthening of the procedure with Endorings (Table 3) .
Data on the comparison between distal attachment devices and SC in terms of cecal intubation rate was available in 15 RCTs 22, 23, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] 37, 40, 43, 45 (10,110 patients). The 2 groups results were perfectly comparable (RR, 1.00; 95% CI, 1.00-1.00; P ¼ .71), with no evidence of heterogeneity (I 2 ¼ 0%). No differences were found in any of the comparisons (Supplementary Figure 6) .
Sensitivity analysis confirmed the earlier-described reported findings (Supplementary Table 4 ).
Small Study Effects and Network Coherence
We did not find any evidence of small study effects based on funnel plot asymmetry and there were no significant differences between direct and indirect estimates in closed loops that allowed assessment of network coherence (P value for difference between groups when both direct and indirect estimates were available were as follows: ADR, P ¼ .41-.44; PDR, P ¼ .35-.37; cecal intubation rate, P ¼ .87-.91; cecal intubation time, P ¼ .27-.32).
Subgroup Analysis and Safety
Subgroup analysis mostly confirmed the results obtained for the whole group (Table 4) . Of note, in the subgroup of lesions 5 mm, risk ratios in favor of Endocuff as compared with SC dramatically increased (RR, 1.53; 95% CI, 1.13-1.71 as for ADR; and RR, 1.38; 95% CI, 1.10-1.43 with regard to PDR).
Adverse events were reported inconsistently, and hence are described qualitatively in Supplementary  Table 5 . No serious adverse event was observed.
Discussion
Recent interest has been raised on the development of novel techniques and devices aimed at improving the ADR. Some of these new technologies, such as fullspectrum endoscopy, 46 balloon-colonoscope system, 47 and Third Eye panoramic cap (Avantis Medical Systems, San Jose, CA) 14, 48 are not widely available because of the high cost and limited expertise. On the other hand, simple add-on devices that can be attached to the tip of the endoscope showed interesting results in terms of increased ADR by flattening colonic folds and enabling a direct view behind them.
Current guidelines 4,49 recognize the interesting role of these devices for improving ADR, even if with conflicting results, but state that definitive assumptions on their superiority over standard colonoscopy or each other cannot be made owing to limited comparative data.
Although several traditional pairwise meta-analyses comparing these devices with standard colonoscopy have been published with conflicting results, 9, 10 there has been limited synthesis of data on their comparative efficacy. Through a network meta-analyses, and using GRADE criteria to appraise the quality of evidence, we made several key observations. First, low-quality evidence supports the use of add-on devices, and in particular Endocuff over SC for improving ADR. However, the anticipated magnitude of benefit is modest, particularly for lowperforming endoscopists (illustrative baseline ADR, 10%), wherein addition of these devices may increase ADR by 1% to 2%. Second, there is very low quality evidence informing the comparative efficacy of different distal attachment devices, mainly owing to the paucity of headto-head trials. With limited evaluation based on a single RCT, Endorings may have a numerically higher ADR as compared with Endocuff and Cap, although Endorings seem to lengthen the procedure, whereas Endocuff and Cap were associated with shorter cecal intubation times and similar cecal intubation rates. Third, a subgroup analysis suggested the benefit of distal attachment devices over SC may be higher for detecting smaller polyps ( 5 mm).
With this updated review, we can suggest low confidence in estimates supporting a modest absolute benefit on ADRs with add-on devices over standard colonoscopy.
Illustratively, in low-performing endoscopists, the estimated ADR by adding add-on devices would be 11.3% (11% with Cap and 12% with Endocuff), whereas in the case of high-performing endoscopists (illustrative baseline ADR, 40%), the estimated ADR with these devices would be 45.2% (43% with Cap and 48% with Endocuff).
Because there is a well-known association between ADR and the risk of interval colorectal cancer, quantified by Corley et al 50 in 3% decrease in the risk of cancer by each 1% increase in ADR, we may postulate that add-on devices may have a very modest effect on decreasing rates of interval CRCs in endoscopists with low ADRs; on the other hand, for high-performing endoscopists, Endocuff may constitute a useful tool (increasing the ADR to 48%), although only a modest effect was observed with Cap.
There were certain limitations, related to both the network analysis as well as individual studies, which merit further discussion. First, there was a paucity of direct head-to-head trials comparing the devices with each other, and all of the included studies were unblinded RCTs, which resulted in low to very low quality evidence of estimates, mainly owing to performance and detection bias. Furthermore, not all the available devices could be analyzed because the only RCT 14 testing the Third Eye panoramic device did not fulfill our inclusion criteria because the study did not report the ADR. Second, network meta-analyses may be subject to misinterpretation as a result of conceptual heterogeneity, related to considerable differences in participants, interventions, co-interventions/background treatment, and outcome assessment, which may limit the comparability of trials. However, heterogeneity was duly taken into account in GRADE appraising of quality of evidence and was a reason for down-rating the evidence provided by the analysis. Moreover, we conducted an extensive subgroup and sensitivity analysis that confirmed the robustness of the primary analysis in all the subsets tested and excluded overt sources of heterogeneity that might have undermined the reliability of our findings. Inclusion of 3 tandem RCTs could represent a limitation to our network meta-analysis because the addition of a second procedure has the benefit of an unblinded second-look colonoscopy; however, our findings were confirmed on a sensitivity analysis restricted to only parallel trials and the very low number of tandem RCTs minimized the potential impact of this aspect on the final results. Of note, when both direct and indirect evidence was available, we observed no difference in effect estimates, supporting the transitivity assumption in our network meta-analysis. Finally, as clearly depicted in the Forest plots available in the Supplementary Figures 2-6 , heterogeneity was owing primarily to differences in effect size and not direction. In addition to limitations in the network metaanalysis, there were several limitations in the individual studies. Although most studies had a broad sample size, the quality of RCTs was mostly moderate, mainly because of the aforementioned performance and detection bias resulting from their unblinded design. Performance and detection bias are not easily avoidable in RCTs testing new devices in endoscopy, given the nature of the intervention under study; nevertheless, randomizing patients to the 2 intervention arms for the detection and removal of all visualized polyps, and then having a second endoscopist blind to results of the first colonoscopy to assess the rate of missed polyps in both groups, could represent a valuable option to decrease the risk of the aforementioned bias. Unfortunately, RCTs with this blinded second-look colonoscopy still are lacking. Results were distinguished in different subgroups only in a relatively small number of RCTs. Some of the comparisons, such as Endocuff vs Cap, relied only on abstract studies, thus limiting the quality of the evidence of findings. Complication rates were poorly reported, preventing a valid assessment of this important outcome and a thorough assessment of the risk-benefit profile. Finally, most RCTs did not report data on the cost of the devices adopted and a cost-effectiveness analysis was beyond the scope of our study.
In conclusion, based on network meta-analysis of all available distal attachment devices, add-on devices result in only modest improvement in ADR, particularly in lowperforming endoscopists, tempering enthusiasm regarding their widespread use. Larger pragmatic trials comparing different distal add-on devices and estimating their impact on reducing risk of interval CRC are warranted.
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